Bone Biologics (BBLG) Other Working Capital Changes (2016 - 2017)
Historic Other Working Capital Changes for Bone Biologics (BBLG) over the last 2 years, with Q4 2017 value amounting to $58828.0.
- Bone Biologics' Other Working Capital Changes rose 259694.4% to $58828.0 in Q4 2017 from the same period last year, while for Dec 2017 it was $24711.0, marking a year-over-year increase of 55134.25%. This contributed to the annual value of -$6682.0 for FY2020, which is 9149.94% up from last year.
- Bone Biologics' Other Working Capital Changes amounted to $58828.0 in Q4 2017, which was up 259694.4% from -$38775.0 recorded in Q3 2017.
- Bone Biologics' Other Working Capital Changes' 5-year high stood at $58828.0 during Q4 2017, with a 5-year trough of -$38775.0 in Q3 2017.